c. diff quick check complete kit (TechLab Inc)
90
Structured Review
TechLab Inc
c. diff quick check complete kit
C. Diff Quick Check Complete Kit, supplied by TechLab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c%2E+diff+quick+check+complete+kit/c++diff+quik+chek+complete/pm38754772-86-30-32
Average 90 stars, based on 1 article reviews
C. Diff Quick Check Complete Kit, supplied by TechLab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c%2E+diff+quick+check+complete+kit/c++diff+quik+chek+complete/pm38754772-86-30-32
Average 90 stars, based on 1 article reviews
c. diff quick check complete kit - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies Article Snippet: Enzyme immunoassay , Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: In this study, we evaluated the Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study Article Snippet: Initial screening used the Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia. Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and Diff-Quik:Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies Article Snippet: Enzyme immunoassay , Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: In this study, we evaluated the Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study Article Snippet: Initial screening used the Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia. Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and Biomarker Discovery:Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies Article Snippet: Enzyme immunoassay , Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: In this study, we evaluated the Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study Article Snippet: Initial screening used the Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia. Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and Immuno Assay:Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies Article Snippet: Enzyme immunoassay , Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: In this study, we evaluated the Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study Article Snippet: Initial screening used the Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia. Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and Surround Optical-fiber Immunoassay:Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies Article Snippet: Enzyme immunoassay , Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: In this study, we evaluated the Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study Article Snippet: Initial screening used the Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia. Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and |